Retinal abnormalities as biomarker of disease progression and early diagnosis of Parkinson disease
Brief description of study
The purpose of this study is to determine if there are abnormalities in the eye structure of patients that have difficulty with controlling movement and/or blood pressure and to investigate whether changes in eye structure can be used to differentiate between neurological conditions and determine disease progression. This study is being sponsored by the Michael J. Fox Foundation for Parkinson’s research.
Clinical Study Identifier: s15-01391
ClinicalTrials.gov Identifier: NCT02640339
If you are registered as a volunteer, please log in to contact the study team/express interest in this study.
